[1]何志军,蒋振兴.陇中消定膏对足舟状骨缺血性坏死的临床疗效观察[J].西部中医药,2013,26(08):25-26.
　HE Zhijun,JIANG Zhenxing.Clinical Observation on LongZhong XiaoDingGao in the Treatment for Ischemic Necrosis of Tarsal Navicular Bone[J].Western Journal of Traditional Chinese Medicine,2013,26(08):25-26.
点击复制

陇中消定膏对足舟状骨缺血性坏死的临床疗效观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年08期
页码:
25-26
栏目:
出版日期:
2013-08-15

文章信息/Info

Title:
Clinical Observation on LongZhong XiaoDingGao in the Treatment for Ischemic Necrosis of Tarsal Navicular Bone
文章编号:
1004-6852(2013)08-0025-02
作者:
何志军，蒋振兴
甘肃省中医院，甘肃 兰州 730050
Author(s):
HE Zhijun, JIANG Zhenxing
Gansu Provincial Hospital of Traditional Chinese Medicine, Lanzhou 730050, China
关键词:
缺血性坏死; 足舟状骨; 陇中消定膏; 中药外敷; 双氯芬酸钠
Keywords:
ischemic necrosis;  navicular bone;  LongZhong XiaoDingGao;  TCM for external use;  diclofenac sodium emulsion
分类号:
R274.32
文献标志码:
A
摘要:
目的：观察陇中消定膏治疗足舟状骨缺血性坏死的疗效。方法：在限制负重的基础上，将 92例足舟状骨缺血性坏死的患者随机分为消定膏治疗组、消定膏+损伤散组、双氯芬酸钠对照组。消定膏治疗组采用中药消定膏外敷，每72小时换药1次；消定膏+损伤散组在消定膏治疗组治疗的基础上口服损伤散0.5 g/次,3次/d；双氯芬酸钠对照组采用双氯芬酸钠乳剂3 g，踝关节下方涂擦，4次/d，20 min/次，治疗12周后观察疗效。结果：3组在改善关节疼痛、僵硬、功能受限等方面与治疗前相比，差异有统计学意义（P＜0.05）,3组治疗后比较，疼痛症状改善无显著性差异（P＞0.05），但消定膏+损伤散组在足功能改善方面效果最佳，消定膏治疗组次之，与双氯芬酸钠乳剂组比较差异有统计学意义。结论：陇中消定膏外敷联合损伤散内服能较好改善足舟状骨缺血性坏死患者的足功能，疗效确切，使用安全方便。
Abstract:
Objective: To explore clinical effects of LongZhong XiaoDingGao in treating ischemic necrosis of tarsal navicular bone. Method: Under the condition of limited weight-bearing, 92 patients were randomized into the treatment group of XiaoDingGao, the group of XiaoDingGao and SunShangSan as well as the control group of diclofenac sodium emulsion. The treatment group of XiaoDingGao received XiaoDingGao for external use, changing the dressing for 72 hours, besides XiaoDingGao, the group of XiaoDingGao and SunShangSan oral SunShangSan, 0.5g each time, three times per day; and the control group diclofenac sodium emulsion for external use beneath the ankle joint, 3g each time, four times each day, 20 minutes once, clinical efficacy was observed after treating for 12 weeks. Result: Three groups were improved in joint pain, stiffness, joint function limitation and others, the difference among three groups had statistical meaning compared with before treating(P＜0.05), the difference in pain improvements had no statistical meaning in the comparison among three groups after treating (P＞0.05), but the group of XiaoDingGao and SunShangSan demonstrated the best effects in improving feet function, the treatment group of XiaoDingGao the next, the comparisons had statistical meaning compared with the control group of diclofenac sodium emulsion. Conclusion: LongZhong XiaoDingGao for external use and oral SunShangSan could improve feet function of the patients with ischemic necrosis of tarsal navicular bone, the treatment, safe and convenient, could gain definite effects.

备注/Memo

备注/Memo:
收稿日期：2013-02-19 作者简介：何志军(1970—)，男，副主任医师。研究方向：手足疾病的诊疗及手足创伤修复。
更新日期/Last Update: 2013-08-15